Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451

A Multi-center, Randomized, Double-Blind, Phase III Clinical Trial to Evaluate the Efficacy and Safety of DWJ1451 in Patients With Hypertension and Dyslipidemia

• the change of sitSBP based on baseline between Treatment arm and control 1 arm [ Time Frame: 8 weeks ]
• the change of LDL-C based on baseline between Treatment arm and control2 arm [ Time Frame: 8 weeks ]

Inclusion Criteria:

• Age 19 to 80 years
• patients with hypertension and hyperlipidemias

Exclusion Criteria:

• orthostatic hypotension
• History of ventricular tachycardia, atrial fibrillation
• uncontrolled diabetes mellitus